Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVEC.L Share News (VEC)

  • There is currently no data for VEC

VEC.L News

Vectura trading in line with expectations
22 Jul 2011

Vectura trading in line with expectations

Inhaled pharmaceutical products maker Vectura said trading has been in line with expectations for the period from 1 April to 21 July, lifting investor...

Wednesday tips round-up: Yell, Vectura, Computacenter...
13 Jul 2011

Wednesday tips round-up: Yell, Vectura, Computacenter...

Is there something to Yell about at last for yet another business struggling to cope with the impact of the internet revolution? asks the Independent....

Tuesday tips round-up: Stobart, Vectura, Mitie
24 May 2011

Tuesday tips round-up: Stobart, Vectura, Mitie

Yesterday, the logistics group Stobart issued full-year figures, with pre-tax profits falling short of market hopes. But the share price rose as the f...

Vectura losses narrow
23 May 2011

Vectura losses narrow

Vectura, the respiratory inhaler firm, reduced losses for the year, drove revenues higher and said it is on track for annual cost-savings of approxima...

London close: Battering for miners and banks
16 Nov 2010

London close: Battering for miners and banks

It was downhill almost all the way for Footsie in the afternoon session after the US opened sharply lower, with miners getting a real bashing on the p...

Sector movers: Vectura lifts pharma stocks after study
16 Nov 2010

Sector movers: Vectura lifts pharma stocks after study

Respiratory inhaler developer Vectura is among the stocks lifting the pharmaceutical sector after positive data from a Phase II clinical study of a tr...

London afternoon: Gloomy miners
16 Nov 2010

London afternoon: Gloomy miners

Footsie retreated further over the lunch time session with mining stocks largely responsible for the decline, as metal prices pull back on fears that ...

Parkinson's treatment results boost Vectura
16 Nov 2010

Parkinson's treatment results boost Vectura

Shares in Vectura moved higher after the respiratory inhaler developer announced higher revenues, sharply narrower losses and positive data from a Pha...